Table.
Drug | Pharmacological group | Mechanism | Phase |
---|---|---|---|
Ambroxol | Pharmacological chaperone | Activation of GCase | II |
Venglustat (GZ/SAR402671) | Substrate reduction therapy | A decrease in the substrate concentration (inhibition of glucosylceramide synthase) | II |
LTI-291 | Pharmacological chaperone | Allosteric activator of GCase | Ib |